Nistico Robert's Form 4 filing
Endovia Health Sciences, Inc. (EDVA) · filed Apr 13, 2023
- Accession no.
- 0001731122-23-000644
- Filed
- Apr 13, 2023
- Trade date
- Apr 13, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $19.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nistico RobertCIK 0001797597 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | Common Stock | PPurchaseAcquired | +7,000 | $1.17 | +$8,190 | 1,357,000 | Direct | |
| Apr 13, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $1.17 | +$11,700 | 1,367,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.